Filling the need for trusted information on national health issues…

HIV/AIDS

  • Your Selections:

Refine Results

date

Tags

Thanks From Global Fund Executive Director Kazatchkine

The Global Fund to Fight AIDS, Tuberculosis and Malaria, “[a]long with our partners, both donors and implementers, [is] changing the story of scores of nations that were once devastated by three killer diseases — diseases which seemed invincible,” Global Fund Executive Director Michel Kazatchkine writes in a Huffington Post opinion piece, adding “we are now saving more than one million lives every year.”

Study Sheds Light On When To Start Antiretroviral Therapy

Findings from a study published in the current issue of the journal Archives of Internal Medicine, when “taken together with other studies published over the last few years,” show that beginning people living with HIV on highly active antiretroviral therapy (HAART) when their CD4 cell count is between 350 and 500…

'Urgent Action' Needed To Prevent Resistance To Antiretroviral Therapy

“The clear pattern of increasing antiretroviral resistance in lower-income settings must be considered in the context of the worldwide HIV-control agenda,” especially because “the increasing rates of antiretroviral resistance in low-income settings represent a potential threat to the emerging treatment-as-prevention strategy,” Evan Wood and Julio Montaner of the BC Centre for Excellence in HIV/AIDS write in a Lancet Infectious Diseases opinion piece, adding, “Urgent action is needed.” They describe steps to help lower the threat of resistance, including deploying proven preventive strategies, “early and sustained” highly active antiretroviral therapy (HAART) to prevent vertical transmission, and programs to provide HAART to 15 million people worldwide by 2015.

HIV Vaccine Research Showing Promise

Recent findings on HIV vaccine research, some presented recently at the AIDS Vaccine 2011 conference in Bangkok, “show that the science of an AIDS vaccine is vibrant and vital,” Mitchell Warren, executive director of AVAC-Global Advocacy for HIV Prevention, writes in a “Science Speaks” guest blog post. “Now is exactly the…

As Interest In Global Health Rises In U.S., San Francisco Stands At Forefront Of Field

The San Francisco Chronicle reports on a growing interest in global health throughout the U.S. and how Jaime Sepulveda, who served as head of epidemiology in Mexico in the early 1980s and who took over the Global Health Sciences division at the University of California, San Francisco (UCSF) earlier this month, “hopes to make the Bay Area a powerhouse in research and development of global health policies worldwide.” The newspaper writes, “In the past five years, global health has taken off at the Bay Area’s top research institutions,” adding, “Both UCSF and Stanford have opened new global health centers, and Kaiser Permanente — the Bay Area’s largest health care provider — has formalized a program to send its doctors and nurses overseas.”

Fight Against HIV Losing Momentum; Robust Analysis Needed To Develop Long-Term Strategy

“After a decade of unprecedented increases in donor funding and a corresponding 17 percent decline worldwide in the number of new infections, the fight against HIV is losing momentum,” Bjorn Lomborg, director of the Copenhagen Consensus Center and an adjunct professor at Copenhagen Business School, and Peter Piot, director of the London School of Hygiene and Tropical Medicine and former executive director of UNAIDS, write in this Wall Street Journal opinion piece.

Multi-Donor Program Improves Availability Of Essential Medicines In Zimbabwe's Public Health Sector

IRIN reports on “[t]he improved availability of essential medicines in Zimbabwe’s public health sector” as a result of “a multi-donor program started in 2008 through collaboration between the government, the U.N. Children’s Fund (UNICEF) Zimbabwe, the European Union (E.U.), the U.K., Australia, Canada and Ireland.” “According to a survey carried out by the E.U., 80 percent of essential medicines are now available at over 80 percent of health facilities compared to only 28 percent availability of vital drugs at public health institutions in 2008,” IRIN notes. The news service writes, “To date, the Essential Medicines Supply Programme (EMSP) has received $52 million in funding, according to UNICEF,” adding, “The money is used to buy drugs and medical supplies which are distributed to health centers by Natpharm, the supply arm of the Ministry of Health and Child Welfare” (9/20).

Early ART Cost Effectiveness In Resource-Poor Settings

A study published in PLoS Medicine shows “that the new WHO guidelines for early [antiretroviral treatment (ART)] initiation can be cost-effective in resource-poor settings, information that should help policymakers in developing countries allocate their often limited resources,” according to a PLoS press release. Bruce Schackman of Weill Cornell Medical College and…

The Henry J. Kaiser Family Foundation Headquarters: 2400 Sand Hill Road, Menlo Park, CA 94025 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KaiserFamilyFoundation | twitter.com/KaiserFamFound

Filling the need for trusted information on national health issues, the Kaiser Family Foundation is a nonprofit organization based in Menlo Park, California.